NASDAQ · SSIIHealthcareSurgical Instruments

SS Innovations International financials

$2.890.00%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$42.5M
Gross profit$19.5M
Gross margin46.0%
Operating income-$8.2M
Net income-$12.1M
Net margin−28.5%
Diluted EPS$-0.06
EBITDA-$7.1M
Operating cash flow-$18.5M
Free cash flow-$22.2M
Diluted shares198.7M

Balance sheet

Period endDec 31
Cash & equivalents$3.2M
Short-term investments$0.00
Total debt$11.4M
Total assets$74.2M
Total liabilities$36.0M
Shareholders' equity$38.2M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology